β-Thalassemia major resulting from compound heterozygosity for HBB: c.92+2T>C [formerly known as IVS-I-2 (T>C)] and a novel β(0)-thalassemia frameshift mutation: HBB: c.209delG; p.Gly70Valfs*20.
about
β-Thalassemia major resulting from compound heterozygosity for HBB: c.92+2T>C [formerly known as IVS-I-2 (T>C)] and a novel β(0)-thalassemia frameshift mutation: HBB: c.209delG; p.Gly70Valfs*20.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
β-Thalassemia major resulting ...... B: c.209delG; p.Gly70Valfs*20.
@en
β-Thalassemia major resulting ...... T>C [formerly known as IVS-I-2
@nl
type
label
β-Thalassemia major resulting ...... B: c.209delG; p.Gly70Valfs*20.
@en
β-Thalassemia major resulting ...... T>C [formerly known as IVS-I-2
@nl
prefLabel
β-Thalassemia major resulting ...... B: c.209delG; p.Gly70Valfs*20.
@en
β-Thalassemia major resulting ...... T>C [formerly known as IVS-I-2
@nl
P2093
P2860
P1433
P1476
β-Thalassemia major resulting ...... B: c.209delG; p.Gly70Valfs*20.
@en
P2093
James D Hoyer
Jennifer L Oliveira
Kenneth C Swanson
Michelle L Kluge
P2860
P304
P356
10.3109/03630269.2014.931286
P577
2014-07-02T00:00:00Z